Focus Partners Wealth
DGX icon

Focus Partners Wealth’s Quest Diagnostics DGX Stock Holding History

Focus Partners Wealth’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.6M Buy
163,327
+12,471
+8% +$2.45M 0.04% 393
2026
Q1 		$29.6M Sell
150,856
-3,126
-2% -$607K 0.03% 403
2025
Q4 		$26.7M Buy
153,982
+12,625
+9% +$2.3M 0.03% 422
2025
Q3 		$26.9M Buy
141,357
+87,300
+161% +$15.5M 0.04% 335
2025
Q2 		$9.71M Sell
54,057
-1,550
-3% -$269K 0.02% 504
2025
Q1 		$9.41M Buy
55,607
+5,123
+10% +$842K 0.02% 488
2024
Q4 		$7.62M Buy
50,484
+14,266
+39% +$2.22M 0.02% 521
2024
Q3 		$5.62M Buy
36,218
+30,469
+530% +$4.55M 0.02% 533
2024
Q2 		$787K Buy
5,749
+67
+1% +$9.18K ﹤0.01% 849
2024
Q1 		$756K Buy
+5,682
New +$737K 0.01% 651

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Focus Partners Wealth's DGX Position: Q2 2026 in Review

Focus Partners Wealth increased its Quest Diagnostics (DGX) stake by 8.3% in Q2 2026, buying an estimated $2.45M and bringing the position to 163,327 shares worth $34.6M. The position accounts for 0.04% of the portfolio, ranked #393.

Focus Partners Wealth first reported a position in DGX in Q1 2024 and has held it in 10 quarters since. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Focus Partners Wealth held 163,327 shares of Quest Diagnostics worth $34.6M as of Q2 2026.
  • Focus Partners Wealth bought 12,471 Quest Diagnostics shares in Q2 2026, an estimated $2.45M.
  • Quest Diagnostics made up 0.04% of Focus Partners Wealth's portfolio in Q2 2026, its #393 holding.
  • Focus Partners Wealth first reported a position in Quest Diagnostics in Q1 2024 and has held it in 10 quarters since.
  • 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.